Cooling is often treated as a stable constant in pharmaceutical processes — until its fails. Deviations rarely happen unexpectedly; they develop gradually and often go unnoticed for too long. By the time they are detected, product quality may already be compromised. So how can companies ensure that their cooling systems remain stable in real-world conditions?